The ability of 111In-anti-γH2AX-TAT to image non-invasively DDR during oncogenesis has since been evaluated in a genetically engineered mouse model of HER2/neu-overexpression driven breast cancer [111]. This evidence concerns the gene ERBB2 and breast carcinoma.